Close Menu

Jeff Kindler's tenure as the CEO of pharmaceutical giant Pfizer was marked by sagging stock prices, a dried-up pipeline, and unexpected changes in strategy, capped by a "coup" of sorts that ultimately cost Kindler his job, reports Fortune magazine. The CEO was called to the airport in Fort Myers, Fla., on December 4, 2010, to "plead for his job" in front of three of the company's board members, write Fortune's Peter Elkind, Jennifer Reingold, and Doris Burke.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.